Literature DB >> 9681276

The effects of diabetes on beta-adrenoceptor mediated responsiveness of human and rat atria.

U D Dinçer1, A Onay, N Ari, A T Ozçelikay, V M Altan.   

Abstract

The literature on the influence of diabetes on cardiac beta-adrenoceptors is still a matter of controversy. Hence, in the present study, the responsiveness of spontaneously beating right atria from streptozotocin (STZ)-diabetic rats to beta-adrenoceptor agonists were compared with those from non-diabetic controls. The responsiveness of right atria from 8-week diabetic rats to the chronotropic effects of isoprenaline, noradrenaline and fenoterol was found to be unchanged. As the disease progressed, on the other hand, the diabetic atria were found to have decreased responsiveness to the chronotropic effects of noradrenaline. The pD2 value and maximum chronotropic effect of noradrenaline were decreased in 14-week diabetic right atria when compared with those from age-matched controls. A significant decrease in the maximum chronotropic response to isoprenaline with no change in pD2 value was also observed in 14-week diabetes. These results suggest that beta 1--but not beta 2-adrenoceptor mediated chronotropic responses were reduced in the right atria due to the increase in the duration of diabetes. On the other hand, the inotropic responses to beta-adrenoceptor agonists were also assessed on diabetic and nondiabetic human atrial tissue. There were no significant differences in the inotropic responses to each agonists in either of the diabetic and nondiabetic human atrial tissues. The full agonist potency order was isoprenaline > or = fenoterol > noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681276     DOI: 10.1016/s0168-8227(98)00034-5

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  10 in total

Review 1.  Cardiac β3 -adrenoceptors-A role in human pathophysiology?

Authors:  Ebru Arioglu-Inan; Gizem Kayki-Mutlu; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-22       Impact factor: 8.739

2.  Parallel effects of β-adrenoceptor blockade on cardiac function and fatty acid oxidation in the diabetic heart: Confronting the maze.

Authors:  Vijay Sharma; John H McNeill
Journal:  World J Cardiol       Date:  2011-09-26

3.  Diabetes decreases mRNA levels of calcium-release channels in human atrial appendage.

Authors:  Sahika Guner; Ebru Arioglu; Aydin Tay; Atalay Tasdelen; Sait Aslamaci; Keshore R Bidasee; U Deniz Dincer
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

4.  Cardiac β-adrenoceptor expression is markedly depressed in Ossabaw swine model of cardiometabolic risk.

Authors:  U Deniz Dincer
Journal:  Int J Gen Med       Date:  2011-06-24

Review 5.  Expression and Signaling of β-Adrenoceptor Subtypes in the Diabetic Heart.

Authors:  Betul R Erdogan; Martin C Michel; Ebru Arioglu-Inan
Journal:  Cells       Date:  2020-11-26       Impact factor: 6.600

Review 6.  The influence of diabetes on cardiac beta-adrenoceptor subtypes.

Authors:  V Melih Altan; Ebru Arioglu; Sahika Guner; A Tanju Ozcelikay
Journal:  Heart Fail Rev       Date:  2007-03-16       Impact factor: 4.654

7.  Decreased expression of beta1- and beta2-adrenoceptors in human diabetic atrial appendage.

Authors:  U Deniz Dinçer; Sahika Güner; Aydin Tay; Ebru Arioğlu; Atilay Taşdelen; Sait Aşlamaci; Keshore R Bidasee
Journal:  Cardiovasc Diabetol       Date:  2003-06-20       Impact factor: 9.951

Review 8.  The functional state of hormone-sensitive adenylyl cyclase signaling system in diabetes mellitus.

Authors:  Alexander O Shpakov; Kira V Derkach
Journal:  J Signal Transduct       Date:  2013-09-28

9.  Increased haemodynamic adrenergic load with isoflurane anaesthesia in type 2 diabetic and obese rats in vivo.

Authors:  Carol T Bussey; Anne E de Leeuw; Regis R Lamberts
Journal:  Cardiovasc Diabetol       Date:  2014-12-10       Impact factor: 9.951

10.  Cardioprotective and β-adrenoceptor antagonistic activity of a newly synthesized aryloxypropanolamine derivative PP-36.

Authors:  Lokesh K Bhatt; Jyotika Bansal; Poonam Piplani; S L Bodhankar; A Veeranjaneyulu
Journal:  J Exp Pharmacol       Date:  2010-02-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.